Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.

Medicine - 1 May 2016

Wang Lizhi, Ding Yan, Wei Lai, Zhao Dewei, Wang Ruoyu, Zhang Yuewei, Gu Xuesong, Wang Zhiqiang

Abstract excerpt

Olfactory neuroblastoma (ONB) is a rare cancer originating in the olfactory epithelium of the nasal vault. The recurrence rate of ONB is high, as the standard treatment of surgery followed by radiotherapy and/or chemotherapy is usually unsuccessful. The use of targeted therapy based on individual genomic variations after cancer relapse has not been reported. Here, we present the case of a 44-year-old man who was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cetuximab
Share to Indoles
Share to Nasal Cavity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nose Neoplasms

Share to Proto-Oncogene Proteins c-ret

Share to Pyrroles

Share to Sunitinib

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Open in PubMed Open full text

Identifiers

PMID: 27149458
DOI: 10.1097/MD.0000000000003536
PMCID: PMC4863775

Genes

EGFR
FGFR2
KDR
RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.PMID 27149458Read ↗

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.Semantic proximity Read ↗

Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatmentSemantic proximity Read ↗

Updated Insights into the Molecular Pathophysiology of Olfactory Neuroblastoma Using Multi-Omics AnalysisSemantic proximity Read ↗

Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.Semantic proximity Read ↗

Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable <i>FGFR3</i> AmplificationsSemantic proximity Read ↗

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.Semantic proximity Read ↗

[Genomic profiles and immune microenvironment of olfactory neuroblastoma].Semantic proximity Read ↗

Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review.Semantic proximity Read ↗

Genomic profiling and immune landscape of olfactory neuroblastoma in ChinaSemantic proximity Read ↗

Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.Semantic proximity Read ↗

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.Semantic proximity Read ↗

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.